1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 2: Class 2 discrepancies in clinically significant findings
Age (yr) Sex NC or CE Context Discrepancies
1 66 F CE F-up meningioma Progression vs stable
2 82 F CE F-up meningioma Progression vs stable
3 47 M NC F-up subdural hematoma Complete resolution vs partial regression
4 60 F NC F-up hydrocephalus Stable vs progression
5 47 F CE F-up metastasis resection No recurrence vs recurrence suspicion
6 77 M CE Lymphoma Normal vs clival lesion
7 76 M NC F-up pituitary apoplexy Unchanged vs new hemorrhage
8 63 M NC F-up glaucoma Optic nerve atrophy vs normal
9 66 M NC F-up subdural hematoma Persistence vs complete resolution
10 64 F NC Post-op adenoma Residual mass vs normal
11 75 F CE Seizures Schizencephaly vs no mention
12 74 M NC F-up subdural hematoma Rebleeding vs no rebleeding
13 58 F CE F-up metastases No recurrence vs recurrence
14 37 F NC F-up glioblastoma Herniation vs no mention
15 62 F CE Breast CA Choroidal mets suspicion vs no mention
16 77 F NC Dementia White matter disease vs no mention
17 76 M CE Memory loss Cerebral trophy vs no mention
18 42 M CE F-up glioblastoma Progression vs stable
Note:—NC indicates noncontrast CT; CE, contrast-enhanced CT; CA, cancer; F-up, follow-up; Post-op, postoperative; mets, metastases.